Clinical Case Studies in Diagnostics and Management of Clostridioides difficile Infection (CDI)

Clinical Care Options (CCO) expert analysis of key concepts in Clostridioides difficile infection diagnosis and management

Sahil Khanna, MBBS, MS
Program Director Teena Chopra, MD, MPH Paul Feuerstadt, MD, FACG, AGAF Kevin Garey, PharmD, MS Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Registered Nurses: 2.0 Nursing contact hours Pharmacists: 2.0 contact hours (0.2 CEUs) Released: April 5, 2022 Expired: April 4, 2023

Introduction

Epidemiology, Pathophysiology, Risk Factors, and Diagnosis

Key Data on Therapeutic Options for Initial C difficile Infection (CDI) Episodes

Recurrent CDI Episodes: The Latest Data and Recommendations on Therapeutic Options

Discussion and Conclusions

Clinical Care Options (CCO) commentary from Dr Teena Chopra on why eradication of C difficile and recognition of modifiable risk factors for recurrence should be the treatment goal

Teena Chopra, MD, MPH Released: March 31, 2022

Clinical Care Options (CCO) commentary from Dr Kevin Garey on the role of treatment goals for initial C difficile infection in reducing significant morbidity and mortality

Kevin Garey, PharmD, MS Released: March 10, 2022

Clinical Care Options (CCO) commentary from Dr Paul Feuerstadt on assessing the risk of recurrent C difficile infection and incorporating new guideline changes when initially treating patients

Paul Feuerstadt, MD, FACG, AGAF Released: February 11, 2022